The analyst views Qualcomm (QCOM) as a long-term accumulation opportunity due to delayed revenue catalysts and existing overhangs, recommending patient buying rather than expecting near-term gains.
The Dragonfly narrative is real but revenue is expected in 2028+, with handset cyclicality and Apple modem transition as overhangs, implying a longer-dated, patient accumulation.
$QCOM is a longer-dated bet IMO, The Dragonfly narrative is real but the revenue is 2028+. Core handset cyclicality and the Apple modem transition remain overhangs. If you’re sizing in, it’s a patient accumulate — not a near-term catalyst play.
| Horizon | Raw move | vs SPY |
|---|---|---|
| 1 day | -7.6% | -6.8% |
| 1 week | -14.0% | -15.4% |
| 1 month | -17.0% | -17.7% |
| 3 months | — | — |
| 6 months | — | — |